UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 253

Sortiert nach

Urinary Incontinence and Erectile Dysfunction After Robotic Versus Open Radical Prostatectomy: A Prospective, Controlled, Nonrandomised Trial

European urology, 2015-08, Vol.68 (2), p.216-225

2015

Link zum Volltext

Verfügbarkeit prüfen

Bi- or multiparametric MRI in a sequential screening program for prostate cancer with PSA followed by MRI? Results from the Göteborg prostate cancer screening 2 trial

European radiology, 2021-11, Vol.31 (11), p.8692-8702

2021

Link zum Volltext

Verfügbarkeit prüfen

Prostate cancer: ESMO Consensus Conference Guidelines 2012

Annals of oncology, 2013-05, Vol.24 (5), p.1141-1162

2013

Link zum Volltext

Verfügbarkeit prüfen

Degree of Preservation of the Neurovascular Bundles During Radical Prostatectomy and Urinary Continence 1 Year after Surgery

European urology, 2015-03, Vol.67 (3), p.559-568

2015

Link zum Volltext

Verfügbarkeit prüfen

Short-term Results after Robot-assisted Laparoscopic Radical Prostatectomy Compared to Open Radical Prostatectomy

European urology, 2015-04, Vol.67 (4), p.660-670

2015

Link zum Volltext

Verfügbarkeit prüfen

Urinary continence recovery and oncological outcomes after surgery for prostate cancer analysed by risk category: results from the LAParoscopic prostatectomy robot and open trial

World journal of urology, 2021-09, Vol.39 (9), p.3239-3249

2021

Link zum Volltext

Verfügbarkeit prüfen

Association of surgeon and hospital volume with short-term outcomes after robot-assisted radical prostatectomy: Nationwide, population-based study

PloS one, 2021-06, Vol.16 (6), p.e0253081-e0253081

2021

Link zum Volltext

Verfügbarkeit prüfen

Screening for prostate cancer: evidence, ongoing trials, policies and knowledge gaps

BMJ Oncology, 2023-10, Vol.2 (1), p.e000039

2023

Link zum Volltext

Verfügbarkeit prüfen

Prostate cancer grading, time to go back to the future

BJU international, 2021-02, Vol.127 (2), p.165-168

2021

Link zum Volltext

Verfügbarkeit prüfen

Active Surveillance for Low-risk Prostate Cancer: Developments to Date

European urology, 2015-04, Vol.67 (4), p.646-648

2015

Link zum Volltext

Verfügbarkeit prüfen

Inherited genetic variant predisposes to aggressive but not indolent prostate cancer

Proceedings of the National Academy of Sciences - PNAS, 2010-02, Vol.107 (5), p.2136-2140

2010

Link zum Volltext

Verfügbarkeit prüfen

The Relationship between Prostate-Specific Antigen and Prostate Cancer Risk: The Prostate Biopsy Collaborative Group

Clinical cancer research, 2010-09, Vol.16 (17), p.4374-4381

2010

Link zum Volltext

Verfügbarkeit prüfen

Agreement between patient reported outcomes and clinical reports after radical prostatectomy - a prospective longitudinal study

BMC urology, 2019-05, Vol.19 (1), p.35-35, Article 35

2019

Link zum Volltext

Verfügbarkeit prüfen

Degree of Preservation of Neurovascular Bundles in Radical Prostatectomy and Recurrence of Prostate Cancer

European urology open science (Online), 2021-08, Vol.30, p.25-33

2021

Link zum Volltext

Verfügbarkeit prüfen

Risk of Recurrent Disease 6 Years After Open or Robotic-assisted Radical Prostatectomy in the Prospective Controlled Trial LAPPRO

European urology open science (Online), 2020-07, Vol.20, p.54-61

2020

Link zum Volltext

Verfügbarkeit prüfen

Post-Radical Prostatectomy Inguinal Hernia: A Simple Surgical Intervention can Substantially Reduce the Incidence—Results From a Prospective Randomized Trial

The Journal of urology, 2010-09, Vol.184 (3), p.984-989

2010

Link zum Volltext

Verfügbarkeit prüfen

Stopping screening, when and how?

Translational andrology and urology, 2018-02, Vol.7 (1), p.46-53

Hugosson, Jonas

2018

Link zum Volltext

Verfügbarkeit prüfen

Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only

The New England journal of medicine, 2022-12, Vol.387 (23), p.2126-2137

2022

Link zum Volltext

Verfügbarkeit prüfen

Reproducibility and Accuracy of Measurements of Free and Total Prostate-Specific Antigen in Serum vs Plasma after Long-Term Storage at -20 {degrees}C

Clinical chemistry (Baltimore, Md.), 2006-02, Vol.52 (2), p.235-239

2006

Link zum Volltext

Verfügbarkeit prüfen

Prostate Cancers in the Prostate-specific Antigen Interval of 1.8–3 ng/ml: Results from the Göteborg-2 Prostate Cancer Screening Trial

European urology, 2024-03

2024

Link zum Volltext

Verfügbarkeit prüfen

Magnetic Resonance Imaging in Active Surveillance of Prostate Cancer: A Systematic Review

European urology, 2015-04, Vol.67 (4), p.627-636

2015

Link zum Volltext

Verfügbarkeit prüfen

The Association Between Age, Prostate Cancer Risk, and Higher Gleason Score in a Long-term Screening Program: Results from the Göteborg-1 Prostate Cancer Screening Trial

European urology, 2022-09, Vol.82 (3), p.311-317

2022

Link zum Volltext

Verfügbarkeit prüfen

Prostate Cancer Diffusion‐Weighted Magnetic Resonance Imaging: Does the Choice of Diffusion‐Weighting Level Matter?

Journal of magnetic resonance imaging, 2022-03, Vol.55 (3), p.842-853

2022

Link zum Volltext

Verfügbarkeit prüfen

Performance of 4Kscore as a Reflex Test to Prostate-specific Antigen in the GÖTEBORG-2 Prostate Cancer Screening Trial

European urology, 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

Results from 22 years of Followup in the Göteborg Randomized Population-Based Prostate Cancer Screening Trial

The Journal of urology, 2022-08, Vol.208 (2), p.292-300

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 253

Suche als RSS-Feed

Aktive Filter

ThemaProstate-Specific Antigen - Blood

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(232)
Mit Volltextzugriff
(182)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Urinary Incontinence and Erectile Dysfunction After Robotic Versus Open Radical Prostatectomy: A Prospective, Controlled, Nonrandomised Trial

Bi- or multiparametric MRI in a sequential screening program for prostate cancer with PSA followed by MRI? Results from the Göteborg prostate cancer screening 2 trial

Prostate cancer: ESMO Consensus Conference Guidelines 2012

Degree of Preservation of the Neurovascular Bundles During Radical Prostatectomy and Urinary Continence 1 Year after Surgery

Short-term Results after Robot-assisted Laparoscopic Radical Prostatectomy Compared to Open Radical Prostatectomy

Urinary continence recovery and oncological outcomes after surgery for prostate cancer analysed by risk category: results from the LAParoscopic prostatectomy robot and open trial

Association of surgeon and hospital volume with short-term outcomes after robot-assisted radical prostatectomy: Nationwide, population-based study

Screening for prostate cancer: evidence, ongoing trials, policies and knowledge gaps

Prostate cancer grading, time to go back to the future

Active Surveillance for Low-risk Prostate Cancer: Developments to Date

Inherited genetic variant predisposes to aggressive but not indolent prostate cancer

The Relationship between Prostate-Specific Antigen and Prostate Cancer Risk: The Prostate Biopsy Collaborative Group

Agreement between patient reported outcomes and clinical reports after radical prostatectomy - a prospective longitudinal study

Degree of Preservation of Neurovascular Bundles in Radical Prostatectomy and Recurrence of Prostate Cancer

Risk of Recurrent Disease 6 Years After Open or Robotic-assisted Radical Prostatectomy in the Prospective Controlled Trial LAPPRO

Post-Radical Prostatectomy Inguinal Hernia: A Simple Surgical Intervention can Substantially Reduce the Incidence—Results From a Prospective Randomized Trial

Stopping screening, when and how?

Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only

Reproducibility and Accuracy of Measurements of Free and Total Prostate-Specific Antigen in Serum vs Plasma after Long-Term Storage at -20 {degrees}C

Prostate Cancers in the Prostate-specific Antigen Interval of 1.8–3 ng/ml: Results from the Göteborg-2 Prostate Cancer Screening Trial

Magnetic Resonance Imaging in Active Surveillance of Prostate Cancer: A Systematic Review

The Association Between Age, Prostate Cancer Risk, and Higher Gleason Score in a Long-term Screening Program: Results from the Göteborg-1 Prostate Cancer Screening Trial

Prostate Cancer Diffusion‐Weighted Magnetic Resonance Imaging: Does the Choice of Diffusion‐Weighting Level Matter?

Performance of 4Kscore as a Reflex Test to Prostate-specific Antigen in the GÖTEBORG-2 Prostate Cancer Screening Trial

Results from 22 years of Followup in the Göteborg Randomized Population-Based Prostate Cancer Screening Trial

Aktive Filter

Suchergebnisse filtern